• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    宾

    宾夕法尼亚州立大学医学院

    Penn State University College of Medicine
    院校
    1.1万论文总数
    31.6万引用总数

    Pennsylvania State University College of Medicine (PSCOM), known simply as Penn State College of Medicine is the medical school of Penn State. While the main Penn State campus is in State College PA, this school is located in Hershey Pennsylvania in order to align with Penn State Milton S. Hershey Medical Center, the medical school’s principal affiliate. The medical school includes 26 basic science and clinical departments and a broad range of clinical programs conducted at its hospital affiliates and numerous ambulatory care sites in the region.

    论文量&引用量时间轴

    机构学者

    论文(10000)

    年份
    起
    –
    止
    排序
    1Reducing Joint Pain Associated with Aromatase Inhibitor Therapy and Improving Medication Adherence in Older Breast Cancer Survivors Through Exercise and Education: Main Results from the REJOIN Randomized Controlled Pilot Trial
    Shirley M. Bluethmann,Emily Dressler, Alana Willis,Katherine Ansley, Cristina Truica, Benita Bowman, Katie Kennedy, Sandra Norona, Sarah Zakrzrewski,Brianna Leitzelar,Case Peters,Maxime Caru,

    Introduction Aromatase inhibitors (AIs) reduce recurrence and mortality in hormone receptor-positive breast cancer; however, up to 70% of patients discontinue therapy early because of AI-associated arthralgia. Joint pain affects more than half of AI users and can be burdensome among breast cancer survivors. Exercise and education may reduce symptoms and improve adherence, but interventions tailored for older survivors remain limited. Materials and methods We evaluated REJOIN, a remotely delivered exercise and education intervention. In this pilot randomized controlled trial, 24 older breast cancer survivors receiving AI therapy were recruited from two cancer centers and randomized to REJOIN or enhanced standard care. The 16-week intervention included supervised resistance and aerobic exercise, education on AI-related side effects, and self-management strategies. Outcomes included joint pain measured by the Brief Pain Inventory and AI adherence measured by the Morisky-Levine-Green Medication Adherence Scale. Additional measures included accelerometer-assessed physical activity and a geriatric assessment. Results Participants (n = 24) had a mean age of 71.4 years (range 60–88), and more than one-third resided in rural communities. Retention was 80% over 12 months. Comparing REJOIN with standard care, changes from baseline to 4 months were evaluated using Wilcoxon tests and Cohen's d effect sizes. REJOIN showed a moderate reduction in joint pain interference (d = −0.47, p = 0.43). Self-reported AI medication adherence was high at baseline in both groups, limiting the ability to detect meaningful improvement; however, adherence patterns over follow-up favored the intervention group. Feasibility benchmarks were met, including accrual of the target sample, retention of 80% at 12 months, and achievement of the prespecified exercise-adherence benchmark, with 12 of 13 intervention participants (94%) completing the required supervised exercise and coaching sessions. Discussion REJOIN was feasible, safe, and acceptable among breast cancer survivors receiving AI therapy. Its remote delivery and engagement of rural participants suggest potential for dissemination and support progression to a larger efficacy trial.

    2027Journal of Geriatric Oncology(2027)
    引用
    AI阅读
    加入学术空间
    2Examining Real-World Implementation of Measurement-Based Care and Its Influence on Emergency Department Visit Risk among Outpatients with Mood and Anxiety Disorders
    Mason T. Breitzig,Gavin N. Rackoff, Tyson S. Barrett,Amber Shergill,Lan Kong, Michelle G. Newman, Erika F. H. Saunders,Guodong Liu

    The practice of using validated rating scales to guide treatment—measurement-based care (MBC) remains underutilized in behavioral health. This study examined the association between real-world MBC implementation, ascertained by measure completion, and emergency department (ED) visits. A retrospective cohort design made use of medical insurance claims data (2015–2023) to examine adult psychiatric outpatients exposed to real-world MBC (“MBC” sample; n = 524); 482 were propensity score-matched to patients who received care as usual (“CAU” sample; n = 964). The index visit was the date of registry enrollment for the MBC sample and the first psychiatric encounter while enrolled for the CAU sample. Time-to-event and negative binomial models were used to estimate hazard ratios (HRs) and incidence rate ratios (IRRs) for ED visits. The overall sample included 1,488 patients (63

    2026Administration and Policy in Mental Health and Mental Health Services Research(2026)引用:38
    引用
    AI阅读
    加入学术空间
    3Long-term Outcomes in Triple-Negative Breast Cancer after a Pathologic Complete Response: Does the Type of Neoadjuvant Therapy Matter?
    Lis Victória Ravani,Seth A. Wander,Marleen Kok,Kelly McCann,Javier Cortes,Romualdo Barroso-Sousa,Maryam Lustberg,José Bines, Isabella Michelon,Laura Testa,Ming Wang, Daxuan Deng,

    Neoadjuvant chemotherapy is standard for stage IB-III triple-negative breast cancer (TNBC), with pathological complete response (pCR) strongly associated with survival. Although escalation with platinum and immune checkpoint inhibitors (ICI) improves pCR and long-term outcomes, patients with pCR in control arms of pivotal trials also show favorable outcomes. Whether the regimen leading to pCR impacts long-term survival is largely unknown. We conducted a systematic review and meta-analysis, searching phase II and III trials including early-stage TNBC patients with pCR. A pooled analysis of Kaplan–Meier-derived individual patient data was performed for event-free survival (EFS) and overall survival (OS), with subgroup analyses by treatment regimens. Of 2830 identified publications, 18 trials comprising 3430 patients were included. Neoadjuvant ICI with chemotherapy improved EFS (HR 0.67; 95

    2026Breast Cancer Research and Treatment(2026)引用:35
    引用
    AI阅读
    加入学术空间
    4Mental Health Diagnoses among Patients with Complex Hypospadias
    Rami Yacoub, Oumaima Kaabi, Melissa D. Gardner,Darios Getahun,Barry A. Kogan, Timothy L. Lash,Peter A. Lee, Joshua May,Courtney McCracken,Suma Vupputuri, David E. Sandberg, Michael Goodman

    This study examines mental health status of patients with complex hypospadias, which include proximal (penoscrotal, scrotal or perineal) hypospadias or hypospadias of any degree with additional urogenital anomalies. Eligible patients of different ages (24

    2026World Journal of Urology(2026)引用:32
    引用
    AI阅读
    加入学术空间
    5Medical Findings in Young Patients with Head Trauma: How Strong is the Evidence for Abuse?
    Kent P. Hymel,Marjan Sjerps,Peter Vergeer

    BACKGROUND AND OBJECTIVE:A Likelihood ratio (LR) is a numerical measure of evidential value. Our objective was to use LRs to express the patient-specific evidential values of medical findings that best differentiate abusive versus non-abusive head trauma (AHT). We hypothesized that the evidential values of patients' AHT-related medical findings would be highly variable. METHODS:We analyzed existing, uniform, prospective, de-identified data regarding 973 acutely head-injured children < 3 years hospitalized for intensive care across 18 sites between 2011 and 2021; applied two different proxies for AHT and non-AHT ground truth; trained and validated statistical models that differentiate AHT versus non-AHT; and analyzed patient-specific LRs in a log10 (LLR) format that facilitated assessment of evidential values (where LLR values > 0 and < 0 supported hypotheses of AHT and non-AHT, respectively). RESULTS:The two best performing statistical models revealed evidential (LLR) values for patient-specific, AHT-related medical findings that varied from modest (-1 to + 1) to relatively large (-2.5 to -1 and + 1 to + 3.5), and values that were misleading (AHT patients with LLR values indicative of non-AHT, and vice versa). A few non-AHT patients presented with misleading evidence that was moderately strong, with LLRs approaching + 3. CONCLUSIONS:Reasonable medical certainty of AHT and non-AHT can be enhanced or limited by the highly variable evidential values of patients' most discriminating medical findings. Physicians can use available LRs to inform their AHT-related diagnostic reasoning, opinions, and testimony.

    2026International Journal of Legal Medicine(2026)引用:28
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 10000 篇论文

    合作机构(100)

    宾夕法尼亚州立大学合作论文 1,097
    宾夕法尼亚州米尔顿·H·赫尔歇医学中心合作论文 749
    匹兹堡大学合作论文 192
    华盛顿大学合作论文 192
    密歇根大学合作论文 164
    宾夕法尼亚大学合作论文 150
    北卡罗来纳大学系统合作论文 141
    加州大学旧金山分校合作论文 126
    美国国家卫生研究院合作论文 124
    杜克大学合作论文 122

    机构统计